313 related articles for article (PubMed ID: 21641935)
1. Immunological function of the endothelial cell within the setting of organ transplantation.
Taflin C; Charron D; Glotz D; Mooney N
Immunol Lett; 2011 Sep; 139(1-2):1-6. PubMed ID: 21641935
[TBL] [Abstract][Full Text] [Related]
2. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation.
Dragun D
Transplantation; 2008 Oct; 86(8):1019-25. PubMed ID: 18946337
[TBL] [Abstract][Full Text] [Related]
3. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
4. Antibody-mediated rejection: treatment alternatives and outcomes.
Singh N; Pirsch J; Samaniego M
Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
[TBL] [Abstract][Full Text] [Related]
5. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the CD4+ T cell allo-immune response by endothelial cells.
Taflin C; Charron D; Glotz D; Mooney N
Hum Immunol; 2012 Dec; 73(12):1269-74. PubMed ID: 22813652
[TBL] [Abstract][Full Text] [Related]
7. Anti-major histocompatibility complex class I-related chain A antibodies in organ transplantation.
Morales-Buenrostro LE; Alberú J
Transplant Rev (Orlando); 2008 Jan; 22(1):27-38. PubMed ID: 18631856
[TBL] [Abstract][Full Text] [Related]
8. Relevance of MICA and other non-HLA antibodies in clinical transplantation.
Sumitran-Holgersson S
Curr Opin Immunol; 2008 Oct; 20(5):607-13. PubMed ID: 18675346
[TBL] [Abstract][Full Text] [Related]
9. Indirect allorecognition in solid organ transplantation.
Harris PE; Cortesini R; Suciu-Foca N
Rev Immunogenet; 1999; 1(3):297-308. PubMed ID: 11256421
[TBL] [Abstract][Full Text] [Related]
10. Non-HLA antibodies post-transplantation: clinical relevance and treatment in solid organ transplantation.
Dragun D; Hegner B
Contrib Nephrol; 2009; 162():129-39. PubMed ID: 19001820
[TBL] [Abstract][Full Text] [Related]
11. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation.
Carter V; Shenton BK; Jaques B; Turner D; Talbot D; Gupta A; Chapman CE; Matthews CJ; Cavanagh G
Transplant Proc; 2005 Mar; 37(2):654-7. PubMed ID: 15848491
[TBL] [Abstract][Full Text] [Related]
12. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression.
Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB
Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766
[TBL] [Abstract][Full Text] [Related]
13. Preformed cytotoxic antibodies in potential allograft recipients: recent data.
Cecka JM; Zhang Q; Reed EF
Hum Immunol; 2005 Apr; 66(4):343-9. PubMed ID: 15866696
[TBL] [Abstract][Full Text] [Related]
14. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.
Ho EK; Vlad G; Vasilescu ER; de la Torre L; Colovai AI; Burke E; Deng M; Schwartz J; Marboe C; Mancini D; Opelz G; Suciu-Foca N
Hum Immunol; 2011 Jan; 72(1):5-10. PubMed ID: 20971146
[TBL] [Abstract][Full Text] [Related]
15. Low immunogenicity of endothelial derivatives from rat embryonic stem cell-like cells.
Ladhoff J; Bader M; Brösel S; Effenberger E; Westermann D; Volk HD; Seifert M
Cell Res; 2009 Apr; 19(4):507-18. PubMed ID: 19238174
[TBL] [Abstract][Full Text] [Related]
16. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
17. Propagation and characterization of lymphocytes from transplant biopsies.
Duquesnoy RJ; Trager JD; Zeevi A
Crit Rev Immunol; 1991; 10(6):455-80. PubMed ID: 1830745
[TBL] [Abstract][Full Text] [Related]
18. The emerging issue of MICA antibodies: antibodies to MICA and other antigens of endothelial cells.
Stastny P; Zou Y; Fan Y; Qin Z; Lavingia B
Contrib Nephrol; 2009; 162():99-106. PubMed ID: 19001817
[TBL] [Abstract][Full Text] [Related]
19. Role of intra-islet endothelial cells in islet allo-immunity.
Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
[TBL] [Abstract][Full Text] [Related]
20. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
Bishop DK; Shelby J; Eichwald EJ
Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
